Rupa R Patel Rachel Presti Laura C Harrison William G Powderly Philip A Chan
10.3851/IMP3208
Antivir Ther
2018;23(4):379-382.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/29168695/
Anti-HIV Agents / therapeutic use HIV Infections / complications HIV Infections / prevention & control Osteoporosis / complications Pre-Exposure Prophylaxis Tenofovir / therapeutic use
Anti-HIV Agents / therapeutic use HIV Infections / complications HIV Infections / prevention & control Osteoporosis / complications Pre-Exposure Prophylaxis Tenofovir / therapeutic use Case Reports Research Support, N.I.H., Extramural Review Anti-HIV Agents / administration & dosage Biomarkers Female Follow-Up Studies HIV Infections / virology Humans Medication Adherence Middle Aged Patient Outcome Assessment Tenofovir / administration & dosage Anti-HIV Agents Biomarkers Tenofovir
PMC6003884
29168695
Tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV prevention in women with osteoporosis: a case report and review of the literature
2018